Ludwig Enterprises, Inc. Share Price

Equities

LUDG

US54973P4019

Market Closed - OTC Markets Other stock markets 01:15:33 24/05/2024 am IST			5-day change	1st Jan Change
0.2 ^USD	-9.09%		-9.09%	+47.60%

16/04	Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
19/03	Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	CI

Financials

Sales 2022	-	Sales 2023	-	Capitalization	21.07M 1.75B
Net income 2022	- 0	Net income 2023	-2M -166M	EV / Sales 2022	-
Net Debt 2022	819K 68.03M	Net Debt 2023	1.26M 105M	EV / Sales 2023	-
P/E ratio 2022	-89.4 x	P/E ratio 2023	-15.8 x	Employees	3
Yield 2022 *	-	Yield 2023	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Ludwig Enterprises, Inc.

Duration

Period

Style

Dynamic Chart

Latest news about Ludwig Enterprises, Inc.

Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	19/03	CI
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	06/03	CI
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	12/02	CI
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	31/01	CI
Ludwig Enterprises, Inc. Announces Executive Changes	02/12	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11	CI
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	16/11	CI
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	19/23/19	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/23/21	CI
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	25/23/25	CI
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	12/23/12	CI
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	15/23/15	CI
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	03/23/03	CI

More news

Press releases Ludwig Enterprises, Inc.

Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024	19/03	AQ
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers	06/03	AQ
Precision Genomics (a Ludwig Company) Will Break Major Medical News at a Presentation for LD Micro Tuesday, Oct. 25th, 2022	24/22/24	NE
Ludwig Enterprises : Hires Anne Blackstone, CRNA as CEO and Director	12/22/12	PU
Ludwig Enterprises : Sucessful 1st Round Funding -- New CEO -- New Division	05/22/05	PU